Author

Yeji Lim

Konkuk UniversityPrimary ORCID profile (0009-0000-4485-6597 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yeji LimiD1 paper · Gwangju Institute of Science and Technology

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:electronic health records· 1 Approach:experimental assay· 1

Frequent Co-Authors

Bok Hee Choi· 1 shared Dong Hyun Kim· 1 shared Harim Kim· 1 shared Hyeryeong LeeiD· 1 shared Jeongbin Kim· 1 shared Jin O‐UchiiD· 1 shared Jin Ryeol AniD· 1 shared Mi Seon SeoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Bok Hee Choi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Blockade of Kv3.1 by MK-801, a PCP-Derivative NMDA Receptor Inhibitor: Implications for Models of Schizophrenia

Tae Jun Park, Sang Woong Park, Solah Park, Yeji Lim, Hyeryeong Lee, Jeongbin Kim, Harim Kim, Dong Hyun Kim, Jin O‐Uchi, Mi Seon Seo, Jin Ryeol An, Bok Hee Choi, Young Min Bae

This study shows MK-801 inhibits Kv3.1 channels in CHO cells, with concentration-, voltage-, and use-dependent effects, suggesting a potential mechanism for its role in schizophrenia models.

bioRxiv · Sep 13, 2026 · PreprintPharmacology & Toxicology